Synopsys's 15-minute chart triggers MACD Death Cross, KDJ Death Cross warning.

Synopsys's 15-minute chart has recently exhibited a MACD Death Cross and KDJ Death Cross at 08/15/2025 10:00. This indicates that the stock price has the potential to continue declining, and the momentum of the stock price is shifting towards the downside, suggesting further potential decreases.

Synopsys (SNPS) has recently shown signs of a potential downward trend in its stock price, as indicated by a MACD Death Cross and KDJ Death Cross on August 15, 2025, at 10:00 AM. These technical indicators suggest that the stock's momentum is shifting towards the downside, potentially signaling further declines [1].

The MACD (Moving Average Convergence Divergence) Death Cross occurs when the MACD line crosses below the signal line, typically indicating a bearish trend. Similarly, the KDJ (Kaufman Adaptive Moving Average) Death Cross signifies a decline in the stock's price momentum. Both of these signals are often seen as precursors to a continued downward trend in stock prices.

Synopsys's recent performance has been robust, with the stock up +12.12% over the last month, outperforming the Computer and Technology sector's gain of 5.15% and the S&P 500's gain of 2% [1]. However, the upcoming earnings release on September 9, 2025, is expected to be closely watched by investors. Analysts anticipate an EPS of $3.84, representing an 11.95% increase from the prior year's quarter, and revenue of $1.77 billion, indicating a 15.9% rise from the same quarter last year [1].

Despite the positive earnings expectations, Synopsys's valuation metrics indicate a premium compared to its industry peers. The stock is currently trading at a Forward P/E ratio of 40.83, which is higher than the industry average of 23.29. Additionally, the PEG ratio of 2.92 is above the industry average of 2.02 [1].

Synopsys's Zacks Rank, which considers estimate revisions and other factors, is currently at #4 (Sell), indicating a cautious outlook from analysts. The Zacks Rank system has a proven track record, with stocks rated #1 (Strong Buy) delivering an average annual return of +25% since 1988 [1].

Given the recent technical indicators and valuation metrics, investors should closely monitor Synopsys's performance and be prepared for potential market volatility. The upcoming earnings release will provide further clarity on the company's financial health and future prospects.

References:
[1] https://finance.yahoo.com/news/synopsys-snps-beats-stock-market-214502983.html